Theralase Technologies 관리
관리 기준 확인 2/4
Theralase Technologies' CEO is Roger Dumoulin-White, appointed in May 2023, has a tenure of 1.5 years. total yearly compensation is CA$405.00K, comprised of 98.8% salary and 1.2% bonuses, including company stock and options. directly owns 4.68% of the company’s shares, worth CA$2.99M. The average tenure of the management team and the board of directors is 14.3 years and 6.4 years respectively.
주요 정보
Roger Dumoulin-White
최고 경영자
CA$405.0k
총 보상
| CEO 급여 비율 | 98.8% |
| CEO 임기 | 1.5yrs |
| CEO 소유권 | 4.7% |
| 경영진 평균 재임 기간 | 14.3yrs |
| 이사회 평균 재임 기간 | 6.4yrs |
최근 관리 업데이트
Recent updates
Is Theralase Technologies (CVE:TLT) In A Good Position To Deliver On Growth Plans?
Jul 29
We're Not Very Worried About Theralase Technologies' (CVE:TLT) Cash Burn Rate
Apr 08Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation
Dec 24Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation
Sep 03CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CA$4m |
| Mar 31 2024 | n/a | n/a | -CA$4m |
| Dec 31 2023 | CA$405k | CA$400k | -CA$5m |
| Sep 30 2023 | n/a | n/a | -CA$4m |
| Jun 30 2023 | n/a | n/a | -CA$5m |
| Mar 31 2023 | n/a | n/a | -CA$5m |
| Dec 31 2022 | n/a | n/a | -CA$5m |
| Sep 30 2022 | n/a | n/a | -CA$6m |
| Jun 30 2022 | n/a | n/a | -CA$5m |
| Mar 31 2022 | n/a | n/a | -CA$5m |
| Dec 31 2021 | n/a | n/a | -CA$4m |
| Sep 30 2021 | n/a | n/a | -CA$4m |
| Jun 30 2021 | n/a | n/a | -CA$4m |
| Mar 31 2021 | n/a | n/a | -CA$5m |
| Dec 31 2020 | n/a | n/a | -CA$6m |
| Sep 30 2020 | n/a | n/a | -CA$8m |
| Jun 30 2020 | n/a | n/a | -CA$8m |
| Mar 31 2020 | n/a | n/a | -CA$8m |
| Dec 31 2019 | n/a | n/a | -CA$7m |
| Sep 30 2019 | n/a | n/a | -CA$5m |
| Jun 30 2019 | n/a | n/a | -CA$4m |
| Mar 31 2019 | n/a | n/a | -CA$3m |
| Dec 31 2018 | CA$301k | CA$300k | -CA$3m |
| Sep 30 2018 | n/a | n/a | -CA$4m |
| Jun 30 2018 | n/a | n/a | -CA$5m |
| Mar 31 2018 | n/a | n/a | -CA$6m |
| Dec 31 2017 | CA$734k | CA$300k | -CA$6m |
보상 대 시장: Roger's total compensation ($USD290.19K) is above average for companies of similar size in the Canadian market ($USD171.96K).
보상과 수익: Roger's compensation has increased whilst the company is unprofitable.
CEO
Roger Dumoulin-White
1.5yrs
테뉴어
CA$405,000
보상
Mr. Roger John Dumoulin-White, B.Sc., P.Eng., Pro. Dir., is President, Chief Executive Officer and Director of Theralase Technologies Inc. from May 2023. He joined the Theralase Technologies Inc. in 2003....
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 1.5yrs | CA$405.00k | 4.68% CA$ 3.0m | |
| CFO & Director | 20.5yrs | CA$260.00k | 1.24% CA$ 788.9k | |
| Chief Scientific Officer & Director | 13.8yrs | CA$310.00k | 0.12% CA$ 77.7k | |
| President of World Trade Division | 18yrs | 데이터 없음 | 데이터 없음 | |
| Equine Medical Consultant | 14.3yrs | 데이터 없음 | 데이터 없음 |
14.3yrs
평균 재임 기간
경험이 풍부한 관리: TLT's management team is seasoned and experienced (14.3 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 1.5yrs | CA$405.00k | 4.68% CA$ 3.0m | |
| CFO & Director | 5.4yrs | CA$260.00k | 1.24% CA$ 788.9k | |
| Chief Scientific Officer & Director | 6.4yrs | CA$310.00k | 0.12% CA$ 77.7k | |
| Independent Director | 16.8yrs | CA$10.00k | 0.76% CA$ 485.7k | |
| Independent Chairman of the Board | 11.8yrs | CA$10.00k | 0.021% CA$ 13.2k | |
| Independent Director | 11.8yrs | CA$10.00k | 0.091% CA$ 58.2k | |
| Member of Medical & Scientific Advisory Board | 9.9yrs | 데이터 없음 | 데이터 없음 | |
| Member of Medical & Scientific Advisory Board | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 1.4yrs | CA$45.13k | 0.0041% CA$ 2.6k |
6.4yrs
평균 재임 기간
경험이 풍부한 이사회: TLT's board of directors are considered experienced (6.4 years average tenure).